IRMA trial reports 5-year local control for partial-breast irradiation
The authors reported a 5-year cumulative ipsilateral breast tumor recurrence of 1.0% (95% CI, 0.6 to 1.6) for APBI versus 0.8% (95% CI, 0.5 to 1.4) for WBI. The hazard ratio for APBI versus WBI was 1.18 (90% CI, 0.63 to 2.20), with the upper confidence limit crossing the prespecified noninferiority margin.
Primary source
PubMed record of a Phase III journal article, November 17, 2026
Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial.
Read the source: Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial. pubmed.ncbi.nlm.nih.gov
Machine-summarized from the source above; not independently reported. How we use automation